Purchases and Sales Made in Q2 2025 in Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN) during Q2 2025. The information is specifically focused on institutions that hold shares of NeuroSense Therapeutics Ltd..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2025
Q2 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
149KNew |
$136K - $372K
|
149K
$188K
|
|
Aug 14, 2025
Q2 2025
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
49.9KNew |
$45.4K - $124K
|
49.9K
$62.9K
|
|
Aug 15, 2025
Q2 2025
|
Morgan Stanley
New York, NY |
BUY
|
- |
29.4K+ 58.21% |
$26.8K - $73.2K
|
79.9K
$101K
|
|
Aug 14, 2025
Q2 2025
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
28.7KNew |
$26.1K - $71.4K
|
28.7K
$36.1K
|
|
Aug 14, 2025
Q2 2025
|
Hrt Financial LP
New York, NY |
BUY
|
- |
21.7KNew |
$19.7K - $54K
|
21.7K
$27.3K
|
|
Aug 13, 2025
Q2 2025
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
11.8KNew |
$10.8K - $29.5K
|
11.8K
$14.9K
|
|
Aug 13, 2025
Q2 2025
|
Jones Financial Companies Lllp
|
BUY
|
- |
10.9KNew |
$9.94K - $27.2K
|
10.9K
$13.8K
|
|
Aug 07, 2025
Q2 2025
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
4.28K+ 2445.71% |
$3.89K - $10.7K
|
4.46K
$5.61K
|
|
Aug 06, 2025
Q2 2025
|
Commonwealth Equity Services, LLC
|
BUY
|
- |
3.83K+ 22.2% |
$3.49K - $9.54K
|
21.1K
$26.6K
|
|
Aug 12, 2025
Q2 2025
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2025
Q2 2025
|
Ubs Group Ag
|
SELL
|
- |
-664- 29.19% |
$604 - $1.65K
|
1.61K
$2.03K
|
|
Aug 13, 2025
Q2 2025
|
Hurley Capital, LLC
New York, NY |
SELL
|
- |
-2.18K- 25.03% |
$1.98K - $5.43K
|
6.53K
$8.23K
|